| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 14 |
| 1 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 9 |
| 2 | LAMIVUDINE ORAL | 6 |
| 3 | AZITHROMYCIN DIHYDRATE | 5 |
| 4 | RALTEGRAVIR | 5 |
| 5 | CLARITHROMYCIN | 4 |
| 6 | EFAVIRENZ | 4 |
| 7 | LEVOFLOXACIN | 4 |
| 8 | LEVOFLOXACIN IN 5% DEXTROSE | 4 |
| 9 | RITONAVIR | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LULICONAZOLE | 2 | 0.0114 |
| 1 | PENTAMIDINE ISETHIONATE | 2 | 0.0016 |
| 2 | ETHAMBUTOL HYDROCHLORIDE | 3 | 0.0011 |
| 3 | RALTEGRAVIR | 5 | 0.0010 |
| 4 | MARAVIROC | 2 | 0.0009 |
| 5 | PROBENECID | 1 | 0.0008 |
| 6 | AMIKACIN SULFATE | 1 | 0.0006 |
| 7 | LAMIVUDINE | 14 | 0.0006 |
| 8 | LAMIVUDINE AND ZIDOVUDINE | 3 | 0.0004 |
| 9 | EFAVIRENZ | 4 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 16 | 0.0003 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0002 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 23 | 0.0002 |
| 4 | Antimalarial [EPC] | 2 | 0.0002 |
| 5 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 6 | Cannabinoid [EPC] | 1 | 0.0001 |
| 7 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 8 | Protease Inhibitor [EPC] | 5 | 0.0001 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |